In November 2022, she was diagnosed with left breast carcinoma with positive hormonal receptors (estrogen receptors: 90-100%; progesterone receptors: 30-40%) and HER2-low status (immunohistochemistry score 1+) with Ki67 at 30%. This evidence concerns the gene ERBB2 and breast carcinoma.